1/20/23 16:14 | 1/19/23 | FATE | Fate Therapeutics Inc | | Health | BioPrd | Biological Products, (No Diag | Mendlein John | CA | D | | M.d | 39 | 1.37 | 0 | 28 | 10 | 311 | D | | | | | | | | | | | | | | |
1/13/23 18:20 | 1/11/23 | FATE | Fate Therapeutics Inc | | Health | BioPrd | Biological Products, (No Diag | Mendlein John | CA | D | | P.m | 698 | 5.60 | 0 | 125 | 79 | 283 | D | | | | | | | | | | | | | | |
6/6/22 16:49 | 6/3/22 | FATE | Fate Therapeutics Inc | | Health | BioPrd | Biological Products, (No Diag | Mendlein John | CA | D | | S | -31 | 22.79 | 0 | -1 | -1 | 158 | D | | | | | | | | | | | | | | |
3/11/22 16:58 | 3/10/22 | FATE | Fate Therapeutics Inc | | Health | BioPrd | Biological Products, (No Diag | Mendlein John | CA | D | | M.d | 51 | 1.63 | 0 | 32 | 25 | 159 | D | | | | | | | | | | | | | | |
3/11/22 16:58 | 3/10/22 | FATE | Fate Therapeutics Inc | | Health | BioPrd | Biological Products, (No Diag | Mendlein John | CA | D | | S.d | -1,105 | 35.02 | 0 | -32 | -17 | 159 | D | | | | | | | | | | | | | | |
12/26/18 16:15 | 12/20/18 | LIFE | Atyr Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Mendlein John | CA | D | | P.m | 103 | 0.4214 | 0 | 245 | 66 | 615 | D | | | | | | | | | | | | | | |
9/5/17 19:41 | 8/31/17 | LIFE | Atyr Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Mendlein John | CA | DO | CEO,Dir | P.d | 100 | 2.65 | 0 | 38 | 11 | 368 | D | | | | | | | | | | | | | | |
4/26/17 17:02 | 4/24/17 | LIFE | Atyr Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Mendlein John | CA | DO | CEO,Dir | P | 0 | 3.00 | 0 | 0 | 0 | 328 | D | | -18 | 12 | 7 | -6 | -4 | 3 | 7 | 3 | -11 | | | | |
4/20/17 19:04 | 4/18/17 | LIFE | Atyr Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Mendlein John | CA | DO | CEO,Dir | P.m | 8 | 3.00 | 0 | 3 | 1 | 328 | D | | -21 | 12 | -7 | -10 | -14 | -7 | -4 | 0 | 12 | | | | |
12/21/16 11:54 | 12/19/16 | LIFE | Atyr Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Mendlein John | CA | DO | CEO,Dir | P | 152 | 2.20 | 1 | 69 | 27 | 325 | D | | -80 | -23 | -35 | -20 | -31 | -40 | -9 | 7 | 7 | 37 | 63 | | |
4/7/16 15:25 | 4/5/16 | LIFE | Atyr Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Mendlein John | CA | DO | CEO,Dir | P | 9 | 3.52 | 1 | 3 | 1 | 251 | D | | | -72 | -66 | -31 | -41 | -36 | -16 | 0 | 25 | 1 | -12 | 1 | 3 |
4/6/16 19:19 | 4/5/16 | LIFE | Atyr Pharma Inc | DE | Health | BioPrd | Biological Products, (No Diag | Mendlein John | CA | DO | CEO,Dir | P | 9 | 3.55 | 1 | 3 | 1 | 248 | D | | | -69 | -62 | -16 | -37 | -31 | -12 | 0 | 20 | 4 | -11 | 0 | 6 |
10/7/13 13:59 | 10/4/13 | FATE | Fate Therapeutics Inc | DE | Health | BioPrd | Biological Products, (No Diag | Mendlein John | CA | D | | P | 100 | 6.00 | 4 | 17 | 12 | 157 | D | | | | | | | | 8 | 18 | -1 | -12 | -8 | 17 | -26 |